Home›Research›Compare›Foxo4-DRI vs Klotho
Peptide ComparisonFoxo4-DRI vs Klotho
Both are Longevity & Cellular peptides.
Foxo4-DRI
Foxo4-D-Retro-Inverso
Half-life: Unknown
14 providers listed
Klotho carries stronger published evidence (Meta-analysis, 8 key studies) than Foxo4-DRI (Review, 3); both are research compounds.
Foxo4-DRI
Klotho
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Klotho |
| More provider options (14 vs 0) | Foxo4-DRI |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
Foxo4-DRI
Klotho
Foxo4-DRI
Rational design of a peptide inducing selective apoptosis of p53-high senescent cells by targeting the FOXO4-…
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigat…
Klotho
Klotho protein and cognitive function: a systematic review and meta-analysis
Association between soluble Klotho levels and calcification propensity T50 in patients with hemodialysis: a c…
Klotho heterozygosity does not modify cognitive decline in APOE ε4 carriers: analysis of a large biobank coho…
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in Mice.
+4 more
About Foxo4-DRI
D-retro-inverso peptide that disrupts Foxo4/p53 interaction in senescent cells; restores p53-mediated apoptosis selectively in senescent cells; clears cellular "zombie cells"
About Klotho
Acts as a co-receptor for FGF23, regulating phosphate and vitamin D metabolism. As a circulating hormone, inhibits insulin/IGF-1 signaling to extend lifespan, activates Nrf2 antioxidant pathways, and suppresses TGF-β fibrotic signaling.
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
Foxo4-DRI
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
Klotho
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Foxo4-DRI
Klotho
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Longevity & Cellular Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). Foxo4-DRI vs Klotho — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/foxo4-dri/klotho